Skip to Content

ENT 200 (Rozlytrek 200 mg)

Generic Name: entrectinib

Pill with imprint ENT 200 is Orange, Capsule-shape and has been identified as Rozlytrek 200 mg. It is supplied by Genentech, Inc..

Rozlytrek is used in the treatment of non-small cell lung cancer; solid tumors and belongs to the drug class multikinase inhibitors. Rozlytrek 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ENT 200

Rozlytrek

Generic Name
entrectinib
Imprint
ENT 200
Strength
200 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0094

Get help with Imprint Code FAQs.

Related Images for "ENT 200"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.